Leadership Overview
Terumo BCT has 4 executives leading key functions including strategy, finance, human resources, and business unit operations.
Driven by innovation, Terumo BCT develops and supplies blood components and cellular technologies, impacting global health through advanced apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies.
Driven by innovation, Terumo BCT develops and supplies blood components and cellular technologies, impacting global health through advanced apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies.
Leadership Roles at Terumo BCT
Antoinette Gawin - President & Chief Executive Officer
Antoinette Gawin, the President & Chief Executive Officer at Terumo BCT, directs the company's overarching strategy and global operations. Gawin steers the organization's mission to develop and supply critical blood components and cellular technologies, ensuring alignment with market needs and advancements in healthcare. Overseeing all business units, Gawin drives innovation in apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies. This leadership role involves fostering strategic partnerships and guiding the company's expansion into new markets, thereby enhancing its impact on patient care worldwide. Antoinette Gawin's vision ensures Terumo BCT remains at the forefront of medical technology, delivering solutions that improve lives.
Russell Spinney - Chief Financial Officer
Russell Spinney, the Chief Financial Officer at Terumo BCT, manages the company's financial health and strategic fiscal planning. Spinney oversees all financial operations, including budgeting, forecasting, and resource allocation, ensuring robust financial performance across global operations. This executive directs the financial strategies that support Terumo BCT's development and supply of blood components and cellular technologies, including apheresis collections and cell therapy systems. By optimizing financial processes and managing investment, Russell Spinney ensures the company's sustained growth and profitability. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding the company's assets and supporting its mission to advance healthcare solutions.
Stuart Bedell - Division Chief Financial Officer, Plasma Innovations Business Unit
Stuart Bedell, the Division Chief Financial Officer, Plasma Innovations Business Unit at Terumo BCT, leads financial strategy specifically for the Plasma Innovations segment. Bedell directs the fiscal operations and financial planning for this critical business unit, ensuring its profitability and strategic alignment with Terumo BCT's broader objectives. This role involves detailed financial analysis, investment oversight, and resource management tailored to the unique demands of plasma-derived therapies and related technologies. Stuart Bedell's expertise supports the innovation and expansion of plasma-based solutions, contributing directly to the company's market leadership. The Division Chief Financial Officer's focus ensures efficient capital deployment and financial integrity within the Plasma Innovations Business Unit.
Bon Lopez - Senior Vice President, Global Human Resources (Chief People Officer)
Bon Lopez, the Senior Vice President, Global Human Resources (Chief People Officer) at Terumo BCT, architects the company's global human capital strategy. Lopez oversees all aspects of talent management, organizational development, and employee engagement, fostering a culture that supports innovation in blood components and cellular technologies. This leadership position drives initiatives to attract, retain, and develop a high-performing workforce across Terumo BCT's international operations. Bon Lopez ensures that human resources policies and practices align with the company's mission to advance healthcare solutions through apheresis collections and cell therapy systems. The Chief People Officer's focus on employee well-being and professional growth is integral to Terumo BCT's sustained success and market impact.
Explore Leadership Teams in Manufacturing
Biomerics designs, develops, and produces medical devices for diagnostic and interventional procedures. Their services include engineering, advanced components, and full contract manufacturing. Their headquarters is in Salt Lake City, Utah.
Company Leadership
CM
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership JC
SR
CH
JW
STERIS plc, founded in 1985 and headquartered in Leicester, United Kingdom, is a global leader in medical manufacturing that develops and markets infection prevention, contamination control, and sterilization products and services. The company provides specialized solutions for healthcare, pharmaceutical, scientific research, industrial, and governmental customers worldwide. STERIS offers a comprehensive range of products including sterilizers, surgical tables, examination lights, operating room equipment, gastrointestinal devices, and cleaning systems. Additionally, the company delivers outsourced services for hospitals and healthcare facilities, including equipment maintenance, sterilization management, and process improvement consulting. Through its network of facilities across multiple continents, STERIS provides contract sterilization services using various technologies such as gamma radiation, electron beam, X-ray, and ethylene oxide gas, along with laboratory testing and validation services.
Company Leadership
MH
PB
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Company Leadership
Frequently Asked Questions Regarding Terumo BCT Top Executives and Leadership Team
